Abstract: Use of agonists and antagonists of the nicotinergic acetylcholine receptors of insects for the non-systemic control of parasitic insects, such as fleas, lice and flies, on humans and on animals.

Abstract: Use of agonists and antagonists of the nicotinergic acetylcholine receptors of insects for the non-systernic control of parasitic insects, such as fleas, lice and flies, on humans and on animals.

Abstract: Use of agonists and antagonists of the nicotinergic acetylcholine receptors of insects for the non-systemic control of parasitic insects, such as fleas, lice and flies, on humans and on animals.

Abstract: The present invention relates to formulations for the dermal control of parasitic insects on humans, having the following composition agonists or antagonists of the nicotinergic acetylcholine receptors of insects in a concentration of from 0.0001 to 12.5% by weight based on the overall weight of the formulation; solvents from the group of the cyclic carbonates in a concentration of from 2.5 to 99.9999% by weight based on the overall weight of the formulation; if desired, further solvents from the group consisting of the alcohols in a concentration of from 0 to 95% by weight based on the overall weight of the formulation; if desired, further auxiliaries from the group of the thickeners, spreading agents, colorants, antioxidants, propellants, preservatives, adhesives, emulsifiers, in a concentration of from 0 up to 30% by weight based on the overall weight of the formulation.

Abstract: Use of agonists and antagonists of the nicotinergic acetylcholine receptors of insects for the non-systemic control of parasitic insects, such as fleas, lice and flies, on humans and on animals.

Abstract: Use of agonists and antagonists of the nicotinergic acetylcholine receptors of insects for the non-systemic control of parasitic insects, such as fleas, lice and flies, on humans and on animals.

Abstract: Use of agonists and antagonists of the nicotinergic acetylcholine receptors of insects for the non-systemic control of parasitic insects, such as fleas, lice and flies, on humans and on animals.

Abstract: The present invention relates to formulations for the dermal control of parasitic insects on animals, having the following compositionagonists or antagonists of the nicotinergic acetylcholine receptors of insects in a concentration of from 1 to 20% by weight based on the overall weight of the formulation;solvents from the group benzyl alcohol or optionally substituted pyrrolidones in a concentration of at least 20% by weight based on the overall weight of the formulation;if desired, further solvents from the group consisting of cyclic carbonates or lactones in a concentration of from 5.0 up to 80% by weight based on the overall weight of the formulation;if desired, further auxiliaries from the group thickeners, spreading agents, colorants, antioxidants, propellants, preservatives, adhesives, emulsifiers, in a concentration of from 0.025 up to 10% by weight based on the overall weight of the formulation.

Abstract: An anthelminthic composition comprising a mixture of phenyl-guanidines of the formula ##STR1## in which R.sup.1 represents hydrogen, optionally substituted alkyl, cycloalkyl, alkoxy, aryl or amino,R.sup.2 represents hydrogen, optionally substituted alkyl, cycloalkyl, alkenyl, alkinyl, aryl, alkoxy or alkenoxy,R.sup.3 represents hydrogen, optionally substituted alkyl, cycloalkyl, alkenyl, alkinyl or aryl,R.sup.4 represents alkyl, alkoxy, phenoxy, alkylthio, phenylthio, phenylsulphinyl, phenylsulphonyl or benzoly which are in each case optionally substituted hy halogen, alkoxy, alkylthio, halogenoalkoxy or halogenoalkylthio, or benzimidazoles of the formula ##STR2## R.sup.3 and R.sup.4 have the meaning specified above together with tetrahydropyrimidines of the formula ##STR3## in which R.sup.5 represents hydrogen or alkyl, R.sup.6 represents optionally substituted phenyl or thienyl, and X represents --(CH.sub.2).sub.2-3 -- or --CH.dbd.CH--.

Abstract: The invention relates to insecticidal formulations which have a pronounced residual action and contain (a) 0.1 to 20% by weight of an insecticidally active compound or compounds, (b) 1 to 40% by weight of a water-soluble gel-forming or lacquer-forming polymer, (c) 40 to 98% by weight of organic, water-miscible solvent, and (d) 0.1 to 10% by weight of one or more further additives.

Abstract: The invention relates to ectoparasiticide-containing polyurethanes which contain spreading agents and ectoparasiticides or mixtures of ectoparasiticides and to said ectoparasiticide-containing polyurethanes in the form of sheets, films, shaped articles, coatings or impregnations. Also included in the invention is the use of said polyurethane compositions for combating ectoparasiticides.

Abstract: The invention relates to ectoparasiticide-containing polyurethane collars for animals containing spreading agents and ectoparasiticides as well as methods for their manufacture.

Abstract: The invention relates to endoparasiticidally effective pastes containing mixtures of 2,2,2-trichloro-1-hydroxyethyl-phosphoric acid dimethyl ester and N-(2-methoxyacetamido-4-phenylthiophenyl)-N',N"-bis-methoxy-carbonylguanid ine and includes a process for the production of said pastes as well as the use of said pastes.

Abstract: An anthelmintic composition suitable for pour-on application to animals for the treatment of helmintic infections which comprises from 0.5 to 40 parts by weight of an anthelmintic agent which is capable of penetrating the skin of the animal to be treated, 0.5 to 50 parts by weight of one or more spreading oils, 20 to 95 parts by weight of one or more suitable organic or inorganic solvents and 0 to 20 parts by weight of one or more auxiliaries.